# Penalty for a pharmaceutical manufacturer's misrepresentation of average sales price of a drug, or biologic — Federal civil penalty maximums — current inflation-adjusted amounts across agencies

For Penalty for a pharmaceutical manufacturer's misrepresentation of average sales price of a drug, or biologic, agency is HHS; statutory authority is 1395w-3a(d)(4)(A); maximum penalty is 17,062, recorded from its source on 2026-08-10.

- **Agency:** HHS _(our reading, not quoted from the source)_
- **Violation:** Penalty for a pharmaceutical manufacturer's misrepresentation of average sales price of a drug, or biologic _(verified: appears in the quote below)_
- **Statutory authority:** 1395w-3a(d)(4)(A) _(verified: appears in the quote below)_
- **Maximum penalty:** 17,062 _(verified: appears in the quote below)_

## What the source says

> 1395w-3a(d)(4)(A) | <https://www.ecfr.gov/current/title-42/section-414.806> 42 CFR 414.806 | CMS | Penalty for a pharmaceutical manufacturer's misrepresentation of average sales price of a drug, or biologic | 2024 | 16,630 | 17,062

## Source

- https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-A/part-102/section-102.3

Last verified: 2026-08-10. Review by: 2027-02-26.
Part of [Federal civil penalty maximums — current inflation-adjusted amounts across agencies](https://referencesource.org/federal-civil-penalty-maximums/).